Stocks of Abbott Laboratories and Reckitt Benckiser Group Plc experienced a sharp decline in the market following the announcement of a new court trial related to allegations that the companies concealed potential risks associated with their formulas for premature infants. This situation has raised significant concern and attention among investors.